CoChat

Analyses of Meldonium (Mildronate) from Blood, Dried Blood Spots (DBS), and Urine Suggest Drug Incorporation into Erythrocytes

Tretzel, L., Görgens, C., Geyer, H., Thomas, A., Dib, J., Guddat, S., Pop, V., Schänzer, W., Thevis, M. · 2016 · International Journal of Sports Medicine
Cited by 39

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Initially developed in the late 1970s for veterinary applications due to proposed growth-promoting effects in animals [ 5 ], meldonium has become an approved drug in selected Eastern European countries and is the subject of ongoing clinical trials focusing the compound’s anti-ischemic and cardioprotective properties [ 2 ] [ 3 ] [ 12 ] [ 15 ] as well as potential applications regarding diabetes, neurodegenerative disorders, and bronchopulmonary diseases. In the context of athletic performance, beneficial effects on the individuals’ physical working capacity, increased endurance performance, and accelerated recovery after physical activity were discussed [ 4 ] [ 10 ] [ 11 ], mentioning oral doses of meldonium of up to 2.0 g per day over 2–3 weeks in the course of pre-competition preparation phases [ 4 ]. In 2015, the World Anti-Doping Agency (WADA) initiated a one-year monitoring program [ 22 ] regarding the prevalence of meldonium (mildronate) in doping controls. Obtained data demonstrated a considerable extent of meldonium use by athletes [ 8 ] [ 16 ], which was further corroborated by a significant number of declarations of use and analytical findings at the Baku 2015 European Games [ 18 ]. Subsequently, the WADA Prohibited List that became effective in January 2016 [ 24 ] classified meldonium as banned under S4 (Hormone and Metabolic Modulators). Pharmacokinetic properties of meldonium were reported for single- and multiple-dose administration studies with healthy volunteers [ 25 ], where the drug’s elimination was monitored in plasma over 24 h post-administration and characterized by non-linear pharmacokinetics. To date, doping controls are based on urine and blood as test matrices, and a variety of alternative matrices including amongst others dried blood spots (DBS) and dried plasma spots (DPS) have been considered lately [ 20 ]. Consequently, the knowledge about factors that potentially influence the elimination of target analytes is of particular importance to sports drug testing and, to the best of our knowledge, the role of erythrocytes and their ability to affect detection windows of meldonium in doping controls (e. g., by incorporation) has not been investigated. Therefore, in the context of a pilot study, DBS, whole blood (Na 2 -EDTA), and urine samples were collected from 2 healthy male volunteers who orally administered meldonium either as single dose (500 mg) or as multi-dose (3×500 mg/day over a period of 6 consecutive days). The study protocol was approved by the local ethics committee of the National Institute for Sports Research (Bucharest, Romania, approval number #162/2016), written consent was obtained from the study participants, and the study was conducted in accordance with ethical standards in sports medicine and exercise science [ 9 ]. DBS samples were collected prior to and post-administration up to 16 days using standard DBS collection cards (Whatman DMPK-C, GE Heathcare Europe, Freiburg, Germany), dried at room temperature, and stored at +4°C in a plastic bag with desiccant until analysis. Na 2 -EDTA-stabilized whole blood specimens (3.5 mL) were sampled within the multi-dose study on day 4 and day 28 post-administration, and aliquots (4×20 µL) were immediately spotted on DBS cards. Further, following centrifugation of the blood samples at 1 000× g for 15 min at 10°C, the plasma was separated from the red blood cell (RBC) fraction, and 200 µL of the RBCs (retained for deposit onto DBS cards) was subsequently washed twice with 600 µL of phosphate-buffered saline (pH 7.4). The obtained plasma and washed erythrocytes were spotted onto DBS cards (four 20 µL aliquots each) and were also stored at +4°C in a plastic bag with desiccant until analysis. Online sample preparation of DBS was performed using a DBS card autosampler (DBSA) directly coupled to an automated solid-phase extraction (SPE) cartridge exchange module (SPE xos ) (Gerstel GmbH, Mülheim a.d.R., Germany). The sample preparation protocol was adapted from a previous application and was optimized to meet the current requirements [ 21 ]. In brief, the spots were extracted by means of flow-through desorption technology using 1 200 µL of acetonitrile/water (70:30, v/v ), which included the online-addition of stable isotope-labeled meldonium (triply deuterated, TRC Toronto, Canada) as internal standard. Sample purification was performed by means of online-SPE using hydrophilic interaction liquid chromatography (HILIC) SPE cartridges. The target compounds were eluted onto the analytical column (Hypersil Gold C8, 2.1 mm×30 mm, 1.9 µm particle size) via the LC mobile phase applying a gradient program with A: 5 mM ammonium acetate buffer (pH 3.5) and B: acetonitrile. LC-HR-MS/MS analysis was performed with a Thermo Dionex Ultimate 3000 liquid chromatograph interfaced to a Q Exactive Plus mass spectrometer (Thermo Scientific, Bremen, Germany). Data were acquired in full scan mode with concomitant targeted higher energy collisional d

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1055/s-0036-1582317

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 39

Metadata

Authors
Tretzel, L., Görgens, C., Geyer, H., Thomas, A., Dib, J., Guddat, S., Pop, V., Schänzer, W., & Thevis, M.
Venue
International Journal of Sports Medicine
Published
2016-05-04
Volume
37
Issue
06
Pages
500-502
ISSN
  • 0172-4622 (ISSN-L)
  • 1439-3964
OpenAlex
W2346119219
Cited by
39
References
1
FWCI
14.29
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Analyses of Meldonium (Mildronate) from Blood, Dried Blood Spots (DBS), and Urine Suggest Drug Incorporation into Erythrocytes. https://app.cochat.ai/papers/10.1055/s-0036-1582317
The paper
Tretzel, L., Görgens, C., Geyer, H., Thomas, A., Dib, J., Guddat, S., Pop, V., Schänzer, W., & Thevis, M. (2016). Analyses of Meldonium (Mildronate) from Blood, Dried Blood Spots (DBS), and Urine Suggest Drug Incorporation into Erythrocytes. International Journal of Sports Medicine. https://doi.org/10.1055/s-0036-1582317

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.